ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Combined Anti-IL6R and CTLA4Ig Therapy Attenuates Recall Alloantibody Responses in a Mouse Model of HLA Sensitization

    N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    [bald]Background[/bald] We previously reported that IL-6 inhibition by anti-IL6R antibody (mMR16-1) or CD28 pathway inhibition using CTLA4Ig (abatacept) reduced recall alloantibody responses in a mouse…
  • 2015 American Transplant Congress

    Frailty in Patients Being Evaluated for Kidney Transplantation

    M. McAdams DeMarco, I. Olorundare, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.

    Johns Hopkins, Baltimore.

    BACKGROUND: In patients undergoing hemodialysis, frailty prevalence is high and predicts mortality and hospitalization. Little is known about frailty in patients with ESRD who are…
  • 2015 American Transplant Congress

    Long-Term Outcomes of Transplantation Using Kidneys from Expanded Criteria Donors

    O. Aubert,1 Kamar,2 Vernerey,1 Viglietti,1 Duong van Huyen,1 Rabant,1 Rostaing,2 Congy,2 Guilbeau-Frugier,2 Martinez,1 Delahousse,1 Glotz,1 Jouven,1 Legendre,1 Lefaucheur,1 Loupy.1

    1Paris Translational Research Center for organ Transplantation, Paris, France; 2Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.

    BackgroundSince the initial definition of ECD established in 2002, their use worldwide has evolved unequally, resulting in a high discard rate. A better understanding of…
  • 2015 American Transplant Congress

    Opportunities in Tacrolimus Therapeutic Drug Monitoring

    N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.

    Department of Pharmacy, NewYork-Presbyterian Hospital, NY.

    Tacrolimus requires diligent therapeutic drug monitoring (TDM) to maintain appropriate serum concentrations after transplant. To optimize efficacy & minimize toxicity frequent levels are drawn, commonly…
  • 2015 American Transplant Congress

    Risk Factors for Infections After Transplant in a Prospective Cohort Study Including Incompatible Kidney Transplant Recipients

    R. Avery,1 H.-L. Tsai,2 C.-Y. Huang,2 S. Shoham,1 D. Ostrander,1 N. Lu,1 R. Montgomery,3 K. Marr.1

    1Infectious Disease, Johns Hopkins, Baltimore, MD; 2Biostatistics and Bioinformatics, Johns Hopkins, Baltimore, MD; 3Transplant Surgery, Johns Hopkins, Baltimore, MD.

    Background: Infectious morbidity is a cumulative function of recurrent events. Historically, data collection has depended on time-to-event analyses, variable definitions, and retrospective data. To better…
  • 2015 American Transplant Congress

    Desensitization Before Living Donor Kidney Transplantation in Highly Sensitized Patients

    E. De Sousa,1 I. Revuelta,1 M. Blasco,1 F. Diekmann,1 J. Cid,2 M. Lozano,2 A. Sánchez-Escuredo,1 J. Martorell,3 E. Palou,3 J. Campistol,1 F. Oppenheimer.1

    1Nephrology, Hospital Clinic Barcelona, Barcelona, Spain; 2Hemotherapy and Hemostasis, Hospital Clinic Barcelona, Barcelona, Spain; 3Immunology, Hospital Clinic Barcelona, Barcelona, Spain.

    Renal transplantation in highly sensitized patients represents a major clinical challenge leading to long periods in the waiting list. When a living donor is available,…
  • 2015 American Transplant Congress

    In House Oxygen Persufflation of Cold Stored Livers Versus Simple Cold Storage in Extended Criteria Liver Grafts: Results of a Randomized Controlled Clinical Trial

    A. Gallinat,1 A. Paul,1 D. Hoyer,1 C. Klein,1 S. Swoboda,1 C. Ose,2 Z. Mathe,1 J. Treckmann,1 T. Minor.3

    1Dept. of General-, Viszeral- und Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Institute of Computer Science in Medicine, Biostatistics and Epidemiology, University Hospital Essen, Essen, Germany; 3Surgical Research Div., Universiy Clinic Surgery, Bonn, Germany.

    Two hours of end-ischemic oxygen persufflation of cold stored porcine livers regenerates cellular energy dependent pathways and improves survival after transplantation. The present trial evaluated…
  • 2015 American Transplant Congress

    U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors

    C. Bhati, I. Tzvetanov, R. Garcia-Roca, J. Oberholzer, E. Benedetti, H. Jeon.

    Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, IL.

    IntroductionA continuous worsening of donor organ shortage has led to expand organ acceptance criteria. It is still theoretically possible to utilize hepatic allografts from donors…
  • 2015 American Transplant Congress

    A Novel Tool to Evaluate Coercion, Pressure, and Motivation in Potential Live Kidney Donors

    A. Shaffer,1 E. King,1 J. Kahn,2 L. Erby,3 D. Segev.1

    1Surgery, Johns Hopkins University, Baltimore, MD; 2Bergman Institute for Bioethics, Johns Hopkins University, Baltimore, MD; 3School of Public Health, Johns Hopkins University, Baltimore, MD.

    Live donor kidney transplantation yields improved graft survival and recipient longevity, as compared to deceased donors. However, one concern with living donation is the potential…
  • 2015 American Transplant Congress

    Addressing Low Live Kidney Donation Rates in African Americans through the Live Donor Champion Program

    E. King,1 J. Garonzik-Wang,3 M. Bowring,1 K. Kumar,1 D. Segev.1,2

    1Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD; 2Epidemiology, Johns Hopkins University, School of Public Health, Baltimore, MD; 3Transplantation, Washington University, School of Medicine, St. Louis, MO.

    Background: African-Americans (AAs) are least likely to receive a live donor kidney transplant, and AAs account for < 20% of all live donors. Differences in…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences